🎯 check Inaxaplin product page
Inaxaplin is a selective, oral small molecule APOL1 channel inhibitor. It affects APOL1 signaling by selectively blocking APOL1 channel function, effectively inhibiting APOL1-mediated renal and glomerular disease progression.